Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: press release not good news

Mag,

The reason I suggested borrowing from Schwartz would be good for us is that the BOD would then have a reason to promote the stock to allow Schwartz massive profits once again.

In my opinion this scenario is the only hope we retail shareholders have.

If this happens you can bet we will be ready to scurry like rats to the exit door marked

"dear broker please sell my PTSC stock quickly"

GG

Share
New Message
Please login to post a reply